Antiviral Research

Article	Citations
RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination	374
Editorial Board	114
Editorial Board	101
Editorial Board	78
Corrigendum to “Crystal structure and cap binding analysis of the methyltransferase of langat virus” [Antivir. Res. 208 (2022) 105459]	70
Editorial Board	68
Novel inhibitors of HSV-1 protease effective in vitro and in vivo	67
Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection: A preclinical study	65
Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice	58
Progress in novel delivery technologies to improve efficacy of therapeutic antibodies	54
Long-term and efficient inhibition of hepatitis B virus replication by AAV8-delivered artificial microRNAs	43
Assessment of the broad-spectrum host targeting antiviral efficacy of halofuginone hydrobromide in human airway, intestinal and brain organotypic models.	41
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier	40
Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models	39
A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT ≤ ULN	36
A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy	35
Berberine promotes K48-linked polyubiquitination of HNF4α, leading to the inhibition of HBV replication	35
Structural and quantitative comparison of viral infection-associated N-glycans in plasma from humans, pigs, and chickens: Greater similarity between humans and chickens than pigs	34
Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals	33
Corrigendum to “The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection” [Antivir. Res. vol 192 (2021) 1–13/105121]	33
Long-term effects of peginterferon-based therapy versus nucleos(t)ide analogue monotherapy in non-cirrhotic HBeAg-positive chronic hepatitis B patients	33
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model	32
Conserved use of the sodium/bile acid cotransporter (NTCP) as an entry receptor by hepatitis B virus and domestic cat hepadnavirus	32
A novel high-throughput single B-cell cloning platform for isolation and characterization of high-affinity and potent SARS-CoV-2 neutralizing antibodies	31
Editorial Board	31

Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection	31
JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase	30
Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses	30
Chemical-induced degradation of PreS2 mutant surface antigen via the induction of microautophagy	28
Discovery and development of INNA-051, a TLR2/6 agonist for the prevention of complications resulting from viral respiratory infections	27
Novel strategy for Poxviridae prevention: Thermostable combined subunit vaccine patch with intense immune response	26
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection	26
N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spread	25
Clinical and experimental evidence for transplacental vertical transmission of flaviviruses	24
Research Alliance for Veterinary Science and Biodefense BSL-3 Network (RAV3N): Report on network origin and phase I activities	24
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?	24
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases	24
Generation of a panel of mutants that are resistant to standard of care therapies in a clinically relevant strain of human cytomegalovirus for drug resistance profiling	23
Therapeutic targeting of organelles for inhibition of Zika virus replication in neurons	23
Inhibition of Chikungunya virus early replication by intracellular nanoantibodies targeting nsP2 Epitope Rich Region	23
Implications of the antiviral drug favipiravir on rabies immunoglobulin for post-exposure prophylaxis of rabies in mice model with category III-like exposures	23
Chelerythrine chloride inhibits Zika virus infection by targeting the viral NS4B protein	23
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies	22
Differential effects of antiretroviral HIV integrase inhibitors on vascular cell adhesion molecules	22
Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides	22
Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP	21
Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction	21
High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection	21
Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial	21
Identification of novel Ebola virus inhibitors using biologically contained virus	21
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19	21
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses	20
Discovery of new antiviral agents through artificial intelligence: In vitro and in vivo results	20
Editorial Board	20
LAVR-289, a broad-spectrum antiviral, protects immunosuppressed Syrian hamsters against lethal adenovirus challenge	20
Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery	20
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD)	20
Design, synthesis and biological evaluation of a novel series of conjugates of N1-(phosphonoalkyl)-1,2,3-triazoles and N3-benzyl-6-bromoquinazoline-2,4-diones with anti-RSV activity	20
Flexible nano-liposomes-encapsulated recombinant UL8-siRNA (r/si-UL8) based on bioengineering strategy inhibits herpes simplex virus-1 infection	20
Intranasal exposure to commensal bacterium Rothia mucilaginosa protects against influenza A virus infection	20
Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies	20
Structural biology of flavivirus NS1 protein and its antibody complexes	20
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2	20
Molecular mechanisms of hepatitis B virus entry inhibition by a bile acid derivative INT-767 binding to the preS1 region	20
MβCD inhibits SFTSV entry by disrupting lipid raft structure of the host cells	20
Targeting PI4KB and Src/Abl host kinases as broad-spectrum antiviral strategy: Myth or real opportunity?	19
Potential application of antiviral coumarin in aquaculture against IHNV infection by reducing viral adhesion to the epithelial cell surface	19
Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB	19
Lipid-targeting antiviral strategies: Current state and future perspectives	19
Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro	19
High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro	19
Biological characterization of AB-343, a novel and potent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity	19
Nucleotide analogues and mpox: Repurposing the repurposable	19
Host factor DUSP5 potently inhibits dengue virus infection by modulating cytoskeleton rearrangement	18
Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection	18

Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism	18
Editorial Board	18
Sulfated β-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis	18
A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus	18
Virus infection and sphingolipid metabolism	17
The diverse roles of peroxisomes in the interplay between viruses and mammalian cells	17
Performance of sofosbuvir and NITD008 in extrahepatic neuronal cells against HEV	17
The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication	17
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2	17
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters	17
Antiviral effect of vesatolimod (GS-9620) against foot-and-mouth disease virus both in vitro and in vivo	17
Eeyarestatin I, an inhibitor of the valosin-containing protein, exhibits potent virucidal activity against the flaviviruses	17
HIV protease inhibitor attenuated astrocyte autophagy involvement in inflammation via p38 MAPK pathway	17
Large-scale deep learning identifies the antiviral potential of PKI-179 and MTI-31 against coronaviruses	17
Targeting the host transcription factor HSF1 prevents human cytomegalovirus replication in vitro and in vivo	17
Editorial Board	16
Editorial Board	16
Hemin protects against Zika virus infection by disrupting virus-endosome fusion	16
Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virus	16
Development of a novel minigenome and recombinant VSV expressing Seoul hantavirus glycoprotein-based assays to identify anti-hantavirus therapeutics	16
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals	16
Antigenic mapping of enterovirus A71 from Taiwan and Southeast Asia	16
RNA virus infections and their effect on host alternative splicing	16
Antiviral drug discovery with an optimized biochemical dengue protease assay: Improved predictive power for antiviral efficacy	15
Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation	15
The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice	15
Editorial Board	15
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants	15
Porcine interferon-α linked to the porcine IgG-Fc induces prolonged and broad-spectrum antiviral effects against foot-and-mouth disease virus	15
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases	15
Construction of a recombinant African swine fever virus with firefly luciferase and eGFP reporter genes and its application in high-throughput antiviral drug screening	15
Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxi	15
Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling	15
Structural and mechanistic insight into the phosphorylation reaction catalyzed by mpox virus thymidine kinase	15
Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication	15
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance	14
Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection	14
Identification of alpha-linolenic acid as a broad-spectrum antiviral against zika, dengue, herpes simplex, influenza virus and SARS-CoV-2 infection	14
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2	14
GS-1 blocks entry of herpes viruses and more broadly inhibits enveloped viruses	14
Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model	14
Identification of West Nile virus RNA-dependent RNA polymerase non-nucleoside inhibitors by real-time high throughput fluorescence screening	14
RNA-Binding motif protein 38 (RBM38) mediates HBV pgRNA packaging into the nucleocapsid	14
Design and synthesis of a new series of hybrids of functionalised N1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus	14
Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models	14
Deubiquitinase USP39 promotes SARS-CoV-2 replication by deubiquitinating and stabilizing the envelope protein	14
Editorial Board	14
Editorial Board	14
Editorial Board	14
Retrospective analysis of steatosis effect on antiviral response and hepatocellular carcinoma risk in chronic hepatitis C	14
Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library	14
Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy	13
CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation	13
A novel cellular tool for screening human pan-coronavirus antivirals	13
25R,26-hydroxycholesterol and an oxysterol synthetic analog inhibit Varicella zoster Virus replication	13
Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections	13
Antiviral strategies against human metapneumovirus: Targeting the fusion protein	13
Salicylamide derivative JMX0312 protects immunosuppressed Syrian hamsters against adenovirus lethal challenge	13
Editorial Board	13
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants	13
High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection	13
History and impact of the mouse-adapted Ebola virus model	13
Editorial Board	13
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication	13
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes	12
Recombinant pseudorabies virus (PRV) expressing stabilized E2 of classical swine fever virus (CSFV) protects against both PRV and CSFV	12
RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5ʹ-untranslated region	12
Exploiting host kinases to combat dengue virus infection and disease	12
Editorial Board	12
Evaluation of panel of neutralising murine monoclonal antibodies and a humanised bispecific antibody against influenza A(H1N1)pdm09 virus infection in a mouse model	12
Mechanisms of action of repurposed Ebola virus antivirals – the roles of phospholipidosis and cholesterol homeostasis	12
Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line	12
The calcium channel inhibitor lacidipine inhibits Zika virus replication in neural progenitor cells	12
Editorial Board	12
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication	12
Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins	12
Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants	12
Influenza antivirals and their role in pandemic preparedness	12
Expanding the anti-flaviviral arsenal: Discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV.	12
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus	12

Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease	12
Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling	12
CD47 expression attenuates Ebola virus-induced immunopathology in mice	12
Editorial Board	12
PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding	12
Antisense oligonucleotides as drugs with both direct and indirect antiviral actions	11
Dynamic features of virus protein 1 and substitutions in the 3-phenyl ring determine the potency and broad-spectrum activity of capsid-binding pyrazolo[3,4-d]pyrimidines against rhinoviruses	11
Effect of antivirals on clinical and lab-adapted human cytomegalovirus strains using induced pluripotent stem cell-derived human neural models	11
Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection	11
Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis	11
Editorial Board	11
Effect of E23G/K, F36V, N37T, E119D, and E199G polymerase acidic protein substitutions on the replication and baloxavir susceptibility of influenza B viruses	11
Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling	11
Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance	11
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains	11
β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus	11
Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study	11
Marburg and Kasokero viruses elicit differential antiviral innate immune control by their natural reservoir bat, the Egyptian rousette (Rousettus aegyptiacus)	11
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus	11
Verteporfin is a broad-spectrum inhibitor of arboviruses and influences viral and host-based events	11
Cholesterol 25-hydroxylase inhibits Newcastle disease virus replication by its architectural damage and blocking HN protein	10
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome	10
Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription	10
α7 nicotinic receptor activation mitigates herpes simplex virus type 1 infection in microglia cells	10
Editorial Board	10
Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumab	10
Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo	10
Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells	10
Editorial Board	10
A bivalent form of a RBD-specific synthetic antibody effectively neutralizes SARS-CoV-2 variants	10
Inhibitors of mpox VP39 2′-O methyltransferase efficiently inhibit the monkeypox virus	10
Development and optimization of biologically contained Marburg virus for high-throughput antiviral screening	10
Association of C-reactive protein polymorphisms with serum-CRP concentration and viral load among dengue-chikungunya mono/co-infected patients	10
New insights into the neuraminidase-mediated hemagglutination activity of influenza A(H3N2) viruses	10
Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study	10
Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: New tricks for old dogs	9
Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families	9
A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D	9
Identification of pan-flavivirus compounds from drug repurposing	9
Assessing the chronic hepatitis B adaptive immune response by profiling specific T-cell receptor repertoire	9
Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the vira	9
Negative regulation of SREBP-1/FAS signaling molecules activates the RIG-1/TBK1-mediated IFN-I pathway to inhibit BVDV replication	9
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro	9
Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023	9
KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells	9
Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization	9
Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation	9
Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA	9
Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production	9
Zika virus replication is impaired by a selective agonist of the TRPML2 ion channel	9
Targeting of the cellular ATM rather than ATR kinase exhibits therapeutic potential during the lumpy skin disease virus infection in vivo and in vitro	9
β-D-N4-hydroxycytidine (NHC, EIDD-1931) inhibits chikungunya virus replication in mosquito cells and ex vivo Aedes aegypti guts, but not when ingested during blood-feeding	9
Identification of oxysterol synthetic analogs as a novel class of late-stage inhibitors of herpes simplex virus 2 replication	9
Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles – A recombinant vaccine candidate	9
Pinostrobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism	9
Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection	9
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2	9
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411	9
Editorial Board	9
Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyond	9
Small molecule direct-acting antivirals for treatment of mpox	9
Identification of Ascomycin against Zika virus infection through screening of natural product library	9
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro	9
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus	9
The ApoA1-mimetic peptide 4F blocks flavivirus NS1-triggered endothelial dysfunction and protects against lethal dengue virus challenge	9
S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants	8
TLR2-mediated mucosal immune priming boosts anti-rhabdoviral immunity in early vertebrates	8
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect	8
Poloxamer 188 – quercetin formulations amplify in vitro ganciclovir antiviral activity against cytomegalovirus	8
ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway	8
Seasonal coronavirus infections trigger NLRP3 inflammasome activation in macrophages but is therapeutically targetable	8
Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infection	8
Design, synthesis, and biological evaluation of novel 2′-deoxy-2′-spirooxetane-7-deazapurine nucleoside analogs as anti-SARS-CoV-2 agents	8
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy	8
The efficiency of high-throughput screening (HTS) and in-silico data analysis during medical emergencies: Identification of effective antiviral 3CLpro inhibitors	8
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera	8
Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster	8
The conserved core nuclear egress complex (NEC) as an antiherpesviral drug target: Pharmacophore-based identification of NEC-specific inhibitors	8
Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates	8
Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry	8
Recombinant porcine interferon cocktail delays the onset and lessens the severity of African swine fever	8
Editorial Board	8
Apatinib inhibits HTNV by stimulating TFEB-driven lysosome biogenesis to degrade viral protein	8
A rapid and versatile reverse genetic approach and visualization animal models for emerging zoonotic pseudorabies virus	8
Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71	8
Editorial Board	8
First evidence of efficacy of peptides targeting the pUL56-pUL89 interaction domain of the human cytomegalovirus terminase complex	8
Pharmacokinetic and safety evaluation of lipopeptide-based HIV fusion inhibitor Lipovirtide in rats	8
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis	8
ESCRT machinery and virus infection	8
Comprehensive database of HIV mutations selected during antiretroviral in vitro passage experiments	8
The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis	8
Identifying hypaphorine as a novel antiviral compound against dengue virus	8
Flavivirus NS4B protein: Structure, function, and antiviral discovery	8
Subcutaneous remdesivir administration prevents interstitial pneumonia in rhesus macaques inoculated with SARS-CoV-2	8